In addition, there are biomarkers, albeit imperfect, for response: microsatellite instability-high (MSI-H) or mismatch repair deficient (MMRd) and high tumor mutational burden (TMB) as well as PD-L1 positivity by immunohistochemistry (IHC). Here, CD274 is linked to neoplasm.